Peripheral Vascular Devices Market Size & Share, by End user (Hospitals, Ambulatory Surgical Centers [ASCs], Specialty Clinics, Cardiac Catheterization Labs, Research Institutes); Artery Type; Material; Application; Technology; Product - Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2026-2035

Peripheral Vascular Devices Market - Regional Analysis

North America Market Insights

North America in the peripheral vascular devices market is anticipated to garner the largest share of 30.5% by the end of 2035. The market’s upliftment is primarily attributed to the increased prevalence of peripheral artery disease, which is readily supported by aging demographics, along with a rise in obesity and diabetes. According to official statistics published by the CDC Government in September 2024, the obesity prevalence in the U.S. among the adult population was 40.3% in August 2023. In addition, the prevalence was higher among adults aged 40 to 59 years than among those aged 20 to 39 years and those aged more than 60 years. Besides, the disease accounted for a 9.4% prevalence, with increasingly higher rates for women than men in each of the age groups. Therefore, with such an increase in the disease, there is a huge peripheral vascular devices market demand in the overall region.

Obesity Prevalence in the U.S. Among Different Adult Age Groups (2023)

Source: CDC Government

The peripheral vascular devices market in the U.S. is growing significantly, owing to the increased disease burden of hypertension and its associated risk factors, a shift to minimally invasive procedures, suitable reimbursement policies, innovative healthcare infrastructure, technological advancement, and the presence of notable manufacturers. As per an article published by the CDC Government in January 2025, high blood pressure has been a primary cause of 664,470 deaths in the country. In addition, 1 in 5 deaths are deliberately related to the pandemic, wherein people had a history of hypertensive disorder. Besides, almost half of adults have high blood pressure, accounting for 48.1%, which is 119.9 million. This is significantly regarded as a systolic blood pressure, which is greater than 130 mm Hg, or a diastolic blood pressure, which is more than 80 mm Hg, thus enhancing the market expansion in the overall country.

The increase in aging demographics, the increase in rare disease prevalence, generous provincial healthcare investment, the integration of minimally invasive techniques, the presence of public health system support, and growing awareness programs are certain factors that are boosting the peripheral vascular devices market in Canada. As stated in an article published by the Open Access Government in October 2025, more than 3 million people across the country are affected by over 7,000 known rare diseases, the majority of which are life-limiting, progressive, and critical. Besides, patients with atypical or rare conditions experience long-lasting diagnostic delays, usually averaging 3.7 years. However, to combat this, the country comprises a patchwork of 13 publicly funded territorial and provincial health systems, with suitable capacity, priorities, and policies that uplift the market growth.

APAC Market Insights

The Asia Pacific in the peripheral vascular devices market is expected to emerge as the fastest-growing region during the forecast period. The market’s development in the region is highly propelled by a rise in the prevalence of lifestyle-based conditions, such as high blood pressure, an increase in the aging population, a fundamental transition towards minimally invasive procedures, and technological advancements in drug-specific stents and balloons. According to official statistics published by OECD in February 2025, countries in the region have an average of 0.1 people more than 65 years for every person of working age. Besides, the increase in the elderly population originates from an increase in life expectancy, owing to optimized health and a continuous decline in birth rates. Moreover, by the end of 2060, it has been estimated that nearly 20% of the regional population in the region is poised to be aged 65 years and older, thereby denoting a huge growth opportunity for the market.

The peripheral vascular devices market in China is gaining increased traction, owing to an acceleration in approval pathways for advanced devices, an escalation in the burden of peripheral artery disease, a surge in the diabetic population, the presence of suitable government healthcare reforms, and expansion in hospital accessibility. As per an article published by NLM in June 2025, the yearly number of peripheral artery disease cases in the country significantly accounts for 2.4 million, of which 1.7 million are female, and 0.7 million are male. Besides, the number of cases for this particular disease is projected to increase to 4.0 million by the end of 2046. Therefore, to overcome this, the development of the 300 Pan-Vascular Management Center in the country has readily signaled a transition to an integrated vascular care, including management and detection of the disease, thereby making it suitable for enhancing the market demand.

The aspects of governmental expenditure on cardiovascular interventions, support by health insurance schemes for offering suitable coverage for vascular procedures, an increase in the number of patients receiving endovascular treatments, and disease awareness are a few trends that are bolstering the peripheral vascular devices market in India. As per an article published by NLM in April 2023, the healthcare system in the country is financed by different sources, with out-of-pocket spending majorly contributing 54.7% of the overall health expenditure. Besides, there exists a huge economic division in the country, with nearly 10.0% of people continuing to reside under the international poverty line of USD 2.1 per day. Therefore, with all these disparities, there is a huge growth opportunity for the market in the country.

Europe Market Insights

Europe in the peripheral vascular devices market is projected to witness considerable growth by the end of the stipulated timeline. The market’s growth in the region is highly fueled by an increase in the incidence of cardiovascular diseases, robust healthcare infrastructure across major economies, the aging demographic, well-established reimbursement policies, and an aggressive emphasis on minimally invasive procedures. According to official statistics published by OECD in December 2025, cardiovascular disease is one of the leading causes of death in the region, readily accounting for 1 in 3 of overall deaths, which is equivalent to 1.7 million deaths as of 2022, and also affecting 62 million people. Besides, ischemic heart disorder is the highest contributor to the disease, which is responsible for nearly 1/3rd, that is 547,000 deaths of total deaths, thereby making it suitable for bolstering the market growth in the overall region.

Cardiovascular Disease Mortality Analysis in Europe (2012-2022)

Source: OECD

The peripheral vascular devices market in Germany is gaining increased exposure, owing to the aging population, sustained need for vascular interventions, healthcare system allocation for substantial resources to interventional cardiology and vascular surgery, and the existence of rigorous safety standards, while ensuring timely market accessibility for advanced products. Based on government estimates published by the ITA in August 2025, the country has an outstanding healthcare sector, with generous expenditure per capita and employing an estimated 6.1 million people. Besides, the domestic medical device industry is considered one of the largest sectors in the country, catering to approximately USD 44 billion in yearly revenue, effectively making up 26.5% of the overall regional market. Besides, 1 in 6 employment opportunities in the country is associated with the healthcare industry, effectively generating a yearly economic footprint of USD 838 billion or an estimated 12.8% of domestic GDP, thus driving the market exposure.

The combination of universal healthcare coverage, robust governmental emphasis on advancement, and centralized procurement efficiencies, continuous patient accessibility across both rural and urban settings, are certain trends that are proliferating the peripheral vascular devices market in France. As per an article published by NLM in May 2025, there has been an increase in specialists, particularly in the country’s private sector, which operates under Sector 2, permitting them to charge fees above standard rates of 38.0% and 57.4% as of 2022. Moreover, the overall healthcare structure comprises a social health insurance that provides nearly 100% coverage for residents. Meanwhile, in terms of expenditure and financing, employee and employer payroll contributions account for approximately 33%, which is followed by 24% for general social contributions, and an estimated 20% for other taxes from value-added tax. Therefore, with the presence of such a health system, the market is gradually expanding in the country.